Aprea Therapeutics Inc.

2.10
-0.10 (-4.55%)
At close: Mar 28, 2025, 3:59 PM
2.23
6.29%
After-hours: Mar 28, 2025, 05:11 PM EDT

Aprea Therapeutics Income Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17
Revenue n/a 583.23K n/a n/a n/a n/a n/a n/a
Cost of Revenue n/a 7.05K 186.44K 271.68K 229.61K 170.25K 8.32K 7.93K
Gross Profit n/a 576.18K -186.44K -271.68K -229.61K -170.25K -8.32K -7.93K
Operating Income -14.32M -15.47M 38.18M -38.04M -52.15M -31.04M -16.49M -15.85M
Interest Income n/a n/a 448.67K 1.65K 222.65K n/a n/a n/a
Pretax Income -12.96M -14.29M -112.66M -37.13M -53.48M -28.06M -15.53M -15.19M
Net Income -12.96M -14.29M -224.88M -36.54M -53.92M -26.41M -15.53M -15.19M
Selling & General & Admin 6.46M 8.42M 20.97M 13.55M 14.93M 8.59M 2.29M 2.46M
Research & Development 9.36M 7.63M 16.4M 23.9M 37.88M 20.95M 14.19M 13.39M
Other Expenses n/a n/a 76.02M n/a n/a n/a n/a n/a
Operating Expenses 15.82M 16.05M 37.37M 37.45M 52.81M 29.54M 16.49M 15.85M
Interest Expense n/a n/a 448.67K n/a 222.65K 156.35K 182.00 15.00
Selling & Marketing Expenses n/a -7.05K n/a n/a n/a n/a n/a n/a
Cost & Expenses n/a 16.06M 37.37M 37.45M 52.81M 29.54M 16.49M 15.85M
Income Tax n/a n/a 112.21M -590.73K 437.99K -1.65M 961.32K -662.13K
Shares Outstanding (Basic) 5.51M 3.62M 82.85K 1.06M 1.06M 1M 703.78K 703.78K
Shares Outstanding (Diluted) 5.51M 3.62M 82.85K 1.06M 1.06M 1M 703.78K 703.78K
EPS (Basic) -2.35 -3.95 -2.71K -34.33 -51.02 -26.28 -22.06 -21.58
EPS (Diluted) -2.35 -3.95 -2.71K -34.33 -51.02 -26.28 -22.06 -21.58
EBITDA -14.32M -14.28M -112.48M -36.86M -53.25M -27.89M -15.52M -15.18M
Depreciation & Amortization n/a 7.05K 186.44K 271.68K 229.61K 170.25K 8.32K 7.93K